Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06512662

Support Pathway for ENT Cancer Patients in a Support Care Day Hospital

Led by Clinique Pasteur Lanroze · Updated on 2026-04-06

60

Participants Needed

1

Research Sites

129 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Cancers of the upper respiratory / digestive tract are a major public health problem, ranking 5th among the most common cancers. Surgery plays a central role in the recommended treatments for this type of pathology. The surgical procedure and its after-effects can be anxiety-provoking and have a major psychological, physical and social impact on patients over the long term. Our institution's standard protocol is based on a pre-operative supportive care day hospital. The aim of this study is to compare our current care pathway with a more extensive interdisciplinary care pathway focused on patients' needs, in order to reduce anxiety and improve the quality of life of patients undergoing surgery for cancers of the upper respiratory / digestive tract. Our aim is to use a prospective single-centre interventional study to assess the impact of adding three post-operative day hospitals to the existing care pathway in terms of reducing anxiety and improving the quality of life of patients undergoing surgery.

CONDITIONS

Official Title

Support Pathway for ENT Cancer Patients in a Support Care Day Hospital

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient undergoing surgery for upper respiratory or digestive tract cancer requiring at least one night's post-operative hospitalisation
  • Understanding of spoken and written French
  • Patient covered by a social security scheme
Not Eligible

You will not qualify if you...

  • Protected patient under a protective measure or legal safeguard
  • Pregnant or breast-feeding patients
  • Patients suffering from major cognitive disorders
  • Patients with major anxiety disorders prior to the onset of cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Clinique Pasteur Lanroze

Brest, France, 29000

Actively Recruiting

Loading map...

Research Team

C

Camille Vuarin, APN

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here